Washington, D.C.’s medical cannabis market took a step back in June 2025, with revenue declining by more than half a million dollars compared to the previous month—even as temporary, out-of-state patients surpassed local residents in dispensary visits and purchases.
According to the Alcoholic Beverage and Cannabis Administration’s latest report, total sales fell from $8,982,688 in May to $8,432,503 in June. The downturn comes amid a notable drop in the number of D.C.-registered medical cannabis patients served, which fell from 17,880 in May to just 13,025 in June. Sales attributed to local patients followed suit, dipping by $182,051 to a total of $3,014,359 for the month.
The slowdown also coincides with a looming expiration of 1,847 local medical patient registrations, a factor that could further thin the city’s core consumer base.
In contrast, temporary patients served from outside the District continued to play an outsized role in the local cannabis economy. That group grew by almost 3,000 patients —from 14,075 in May to 17,052 in June— which significantly outpaced D.C. residents in dispensary sales. Maryland, Virginia and Florida remained the top three sources of out-of-state patients through the District’s reciprocity program, though each state reported fewer visiting patients than in the prior month.
The downturn extended beyond patient numbers to include product sales and supply chain metrics. Manufacturer sales dropped from $2,487,653 to $2,253,106, and all product categories saw decreased sales except for three: vape products, infused prerolls and concentrates, which bucked the trend and continued to grow.
Dispensary performance also softened slightly. With 48 retail locations open in June, average sales per dispensary fell to $113,044, down from $125,761 in May.
Despite the month-to-month dip, the broader picture remains one of expansion. June 2025 sales nearly doubled compared to the same period last year, when revenue totaled just $4,394,417—underscoring the longer-term growth of the city’s legal cannabis market, even amid short-term fluctuations.
June in short
- Total revenue fell to $8.43M, down $550K from May’s $8.98M
- D.C. patients served dropped from 17,880 (May) to 13,025 (June)
- Temporary out-of-state patients served: 17,052 — outnumbered D.C. residents by over 4,000
- Top reciprocity states: Maryland, Virginia, Florida — all saw patient declines
- D.C. patient sales fell by $182,051 ($3.20M to $3.01M)
- 1,847 local patient registrations set to expire soon
- Manufacturer sales decreased to $2.25M, down from $2.49M
- Dispensaries open: 48 in June
- Average sales per dispensary dropped to $113,044 (from $125,761 in May)
- Year-over-year growth remained strong from June 2024 revenue ($4.39M) to June 2025 revenue ($8.43M) almost doubling.
